Cargando…
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
AIMS/HYPOTHESIS: Transcriptome analyses revealed insulin-gene-derived transcripts in non-beta endocrine islet cells. We studied alternative splicing of human INS mRNA in pancreatic islets. METHODS: Alternative splicing of insulin pre-mRNA was determined by PCR analysis performed on human islet RNA a...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036285/ https://www.ncbi.nlm.nih.gov/pubmed/36884057 http://dx.doi.org/10.1007/s00125-023-05882-y |
_version_ | 1784911617313472512 |
---|---|
author | van Tienhoven, René Kracht, Maria J. L. van der Slik, Arno R. Thomaidou, Sofia Wolters, Anouk H. G. Giepmans, Ben N. G. Riojas, Juan Pablo Romero Nelson, Michael S. Carlotti, Françoise de Koning, Eelco J. P. Hoeben, Rob C. Zaldumbide, Arnaud Roep, Bart O. |
author_facet | van Tienhoven, René Kracht, Maria J. L. van der Slik, Arno R. Thomaidou, Sofia Wolters, Anouk H. G. Giepmans, Ben N. G. Riojas, Juan Pablo Romero Nelson, Michael S. Carlotti, Françoise de Koning, Eelco J. P. Hoeben, Rob C. Zaldumbide, Arnaud Roep, Bart O. |
author_sort | van Tienhoven, René |
collection | PubMed |
description | AIMS/HYPOTHESIS: Transcriptome analyses revealed insulin-gene-derived transcripts in non-beta endocrine islet cells. We studied alternative splicing of human INS mRNA in pancreatic islets. METHODS: Alternative splicing of insulin pre-mRNA was determined by PCR analysis performed on human islet RNA and single-cell RNA-seq analysis. Antisera were generated to detect insulin variants in human pancreatic tissue using immunohistochemistry, electron microscopy and single-cell western blot to confirm the expression of insulin variants. Cytotoxic T lymphocyte (CTL) activation was determined by MIP-1β release. RESULTS: We identified an alternatively spliced INS product. This variant encodes the complete insulin signal peptide and B chain and an alternative C-terminus that largely overlaps with a previously identified defective ribosomal product of INS. Immunohistochemical analysis revealed that the translation product of this INS-derived splice transcript was detectable in somatostatin-producing delta cells but not in beta cells; this was confirmed by light and electron microscopy. Expression of this alternatively spliced INS product activated preproinsulin-specific CTLs in vitro. The exclusive presence of this alternatively spliced INS product in delta cells may be explained by its clearance from beta cells by insulin-degrading enzyme capturing its insulin B chain fragment and a lack of insulin-degrading enzyme expression in delta cells. CONCLUSIONS/INTERPRETATION: Our data demonstrate that delta cells can express an INS product derived from alternative splicing, containing both the diabetogenic insulin signal peptide and B chain, in their secretory granules. We propose that this alternative INS product may play a role in islet autoimmunity and pathology, as well as endocrine or paracrine function or islet development and endocrine destiny, and transdifferentiation between endocrine cells. INS promoter activity is not confined to beta cells and should be used with care when assigning beta cell identity and selectivity. DATA AVAILABILITY: The full EM dataset is available via www.nanotomy.org (for review: http://www.nanotomy.org/OA/Tienhoven2021SUB/6126-368/). Single-cell RNA-seq data was made available by Segerstolpe et al [13] and can be found at https://sandberglab.se/pancreas. The RNA and protein sequence of INS-splice was uploaded to GenBank (BankIt2546444 INS-splice OM489474). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05882-y) contains peer-reviewed but unedited supplementary material.. |
format | Online Article Text |
id | pubmed-10036285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-100362852023-03-25 Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells van Tienhoven, René Kracht, Maria J. L. van der Slik, Arno R. Thomaidou, Sofia Wolters, Anouk H. G. Giepmans, Ben N. G. Riojas, Juan Pablo Romero Nelson, Michael S. Carlotti, Françoise de Koning, Eelco J. P. Hoeben, Rob C. Zaldumbide, Arnaud Roep, Bart O. Diabetologia Article AIMS/HYPOTHESIS: Transcriptome analyses revealed insulin-gene-derived transcripts in non-beta endocrine islet cells. We studied alternative splicing of human INS mRNA in pancreatic islets. METHODS: Alternative splicing of insulin pre-mRNA was determined by PCR analysis performed on human islet RNA and single-cell RNA-seq analysis. Antisera were generated to detect insulin variants in human pancreatic tissue using immunohistochemistry, electron microscopy and single-cell western blot to confirm the expression of insulin variants. Cytotoxic T lymphocyte (CTL) activation was determined by MIP-1β release. RESULTS: We identified an alternatively spliced INS product. This variant encodes the complete insulin signal peptide and B chain and an alternative C-terminus that largely overlaps with a previously identified defective ribosomal product of INS. Immunohistochemical analysis revealed that the translation product of this INS-derived splice transcript was detectable in somatostatin-producing delta cells but not in beta cells; this was confirmed by light and electron microscopy. Expression of this alternatively spliced INS product activated preproinsulin-specific CTLs in vitro. The exclusive presence of this alternatively spliced INS product in delta cells may be explained by its clearance from beta cells by insulin-degrading enzyme capturing its insulin B chain fragment and a lack of insulin-degrading enzyme expression in delta cells. CONCLUSIONS/INTERPRETATION: Our data demonstrate that delta cells can express an INS product derived from alternative splicing, containing both the diabetogenic insulin signal peptide and B chain, in their secretory granules. We propose that this alternative INS product may play a role in islet autoimmunity and pathology, as well as endocrine or paracrine function or islet development and endocrine destiny, and transdifferentiation between endocrine cells. INS promoter activity is not confined to beta cells and should be used with care when assigning beta cell identity and selectivity. DATA AVAILABILITY: The full EM dataset is available via www.nanotomy.org (for review: http://www.nanotomy.org/OA/Tienhoven2021SUB/6126-368/). Single-cell RNA-seq data was made available by Segerstolpe et al [13] and can be found at https://sandberglab.se/pancreas. The RNA and protein sequence of INS-splice was uploaded to GenBank (BankIt2546444 INS-splice OM489474). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05882-y) contains peer-reviewed but unedited supplementary material.. Springer Berlin Heidelberg 2023-03-08 2023 /pmc/articles/PMC10036285/ /pubmed/36884057 http://dx.doi.org/10.1007/s00125-023-05882-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article van Tienhoven, René Kracht, Maria J. L. van der Slik, Arno R. Thomaidou, Sofia Wolters, Anouk H. G. Giepmans, Ben N. G. Riojas, Juan Pablo Romero Nelson, Michael S. Carlotti, Françoise de Koning, Eelco J. P. Hoeben, Rob C. Zaldumbide, Arnaud Roep, Bart O. Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
title | Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
title_full | Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
title_fullStr | Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
title_full_unstemmed | Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
title_short | Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
title_sort | presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036285/ https://www.ncbi.nlm.nih.gov/pubmed/36884057 http://dx.doi.org/10.1007/s00125-023-05882-y |
work_keys_str_mv | AT vantienhovenrene presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT krachtmariajl presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT vanderslikarnor presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT thomaidousofia presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT woltersanoukhg presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT giepmansbenng presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT riojasjuanpabloromero presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT nelsonmichaels presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT carlottifrancoise presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT dekoningeelcojp presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT hoebenrobc presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT zaldumbidearnaud presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells AT roepbarto presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells |